Vital Therapies reported $3K in Ordinary Share Capital for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ordinary Share Capital Change
Biomarin Pharmaceutical BMRN:US $ 0.18M 0M
Dynavax Technologies DVAX:US $ 0.12M 0.01M
Epizyme EPZM:US $ 0.01M 0M
Insmed INSM:US $ 1.18M 32K
Mirati Therapeutics MRTX:US $ 0.05M 0M
Omeros OMER:US $ 625K 1000
Quidel QDEL:US $ 0.04M 0M
Revance Therapeutics RVNC:US $ 0.07M 0M
Ultragenyx Pharmaceutical RARE:US $ 0.07M 0M
United Therapeutics UTHR:US $ 0.7M 0M
Vital Therapies VTL:US $ 0M 0M
Xoma XOMA:US $ 85K 0